Psilocybin Mushrooms in Victoria: Species, Risks, and Legal Status

Victoria is home to a diverse range of psilocybin-containing mushrooms. The state is particularly well-known for Psilocybe subaeruginosa, a species that grows abundantly in its forests, parks, and pine plantations. Consequently, Victoria has become a focal point for both scientific study and recreational interest in these fungi. This guide provides an educational overview of the species found in Victoria, the significant risks associated with their use, and the strict legal framework governing them.
Key Species Found in Victoria
Victoria hosts several species of psilocybin mushrooms. The most prominent is Psilocybe subaeruginosa, which is widespread across the state. You will commonly find it in urban parks, gardens, pine plantations, and native forests, growing on wood chips, pine needles, and other woody debris. Other species that have been documented in Victoria include Psilocybe australiana (now considered a variant of P. subaeruginosa), Psilocybe cubensis, Copelandia cyanescens, and Gymnopilus junonius. There are an estimated 20 to 30 species of magic mushrooms in Australia, some of which are native, while others have been introduced.
The Unique Risk: Wood-Lover Paralysis
One of the most significant and poorly understood risks associated with Psilocybe subaeruginosa is a condition known as wood-lover paralysis. This is a rare but serious complication involving acute muscle weakness following ingestion.
Recent clinical research from Victoria has documented three cases of wood-lover paralysis, highlighting the variable severity of the condition. These cases ranged from mild generalized weakness affecting gait to severe weakness involving both upper and lower limbs, and in one instance, respiratory failure requiring intubation. The study confirmed that the mushrooms involved were Psilocybe subaeruginosa, based on DNA sequence data, and detected psilocin in the patients’ serum. This establishes a clear causal link between the species and the syndrome.
The exact cause of wood-lover paralysis remains unknown, though researchers hypothesise it may be due to an additional tryptamine produced by the mushrooms. A survey of magic mushroom users found that 42% reported experiencing some form of weakness after consuming mushrooms, with the vast majority of those cases linked to wood-growing species like P. subaeruginosa, rather than dung-inhabiting species like P. cubensis. The symptoms can appear within four hours of ingestion and can last from a few hours to up to three days.
The Tragic Context: A Victorian Coroner’s Case
The risks of unregulated psilocybin use were tragically highlighted by a Victorian coroner’s investigation into the death of Rachael Dixon in 2024. Ms. Dixon died after consuming magic mushroom tea at an unregulated wellness retreat in Clunes, Victoria. The coroner found that her death occurred “in the context” of her recent use of psilocybin, although no clear cause of death could be determined. The report noted that Ms. Dixon’s symptoms, which included an inability to walk, appeared consistent with wood-lover paralysis. This case underscores the potential severity of adverse effects and the dangers of consuming psilocybin outside of a controlled medical setting.
The Legal Status of Psilocybin in Victoria
Psilocybin and psilocin are illegal substances in Victoria for general use. Possessing, using, or supplying them is a criminal offence. The legal framework is based on the Drugs, Poisons and Controlled Substances Act 1981 (Vic), which classifies psilocybin as a Schedule 11 poison, the most restricted category.
In a landmark decision, Australia became the first country to reclassify psilocybin as a medicine for specific therapeutic uses. Since July 1, 2023, the Therapeutic Goods Administration (TGA) has permitted the prescribing of psilocybin for treatment-resistant depression (TRD). For this specific use, psilocybin is a Schedule 8 (Controlled Drug) medicine. However, only authorised psychiatrists can prescribe it through the TGA’s Authorised Prescriber scheme. As of mid-2026, only about 40 psychiatrists hold such approvals across the country, and approximately 74 patients have received psilocybin therapy outside of clinical trials.
Conclusion
Victoria is home to a diverse range of psilocybin mushrooms, most notably Psilocybe subaeruginosa. While these fungi have attracted scientific and recreational interest, the risks associated with their use are significant. The syndrome of wood-lover paralysis can cause severe muscle weakness, and in rare cases, respiratory failure. The death of a woman in Victoria following psilocybin consumption highlights the potential for fatal outcomes. It is also critical to be aware of the deadly lookalike species that grow in the same habitats, such as Galerina species. Consequently, the only legal and safe access to psilocybin in Australia is through a strict medical pathway for treatment-resistant depression. This guide is for educational and research purposes only and does not constitute legal advice.
